Other substances

(4Ar,5R,6aS,6aR,6bR,8aS,11R,14aR,14bR)-5-hydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-2,4a,5,6,6a,7,8,9,10,13,14,14a-dodecahydro-1H-picen-3-one

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

(4Ar,5R,6aS,6aR,6bR,8aS,11R,14aR,14bR)-5-hydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-2,4a,5,6,6a,7,8,9,10,13,14,14a-dodecahydro-1H-picen-3-one on PubChem

Synonyms

CHEMBL2022920

 

Structure image - (4Ar,5R,6aS,6aR,6bR,8aS,11R,14aR,14bR)-5-hydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-2,4a,5,6,6a,7,8,9,10,13,14,14a-dodecahydro-1H-picen-3-one

C[C@]12CC[C@@](C=C1[C@H]3CC[C@@H]4[C@]5(CCC(=O)C([C@@H]5[C@@H](C[C@]4([C@@]3(CC2)C)C)O)(C)C)C)(C)CO

Supporting references

Link Tested on Impact factor Notes Publication date
Identification of the binding interactions of some novel antiviral compounds against Nsp1 protein from SARS-CoV-2 (COVID-19) through high throughput screening
nsp1 Small molecule In silico 		in silico 3.22

Predicted to bind SARS-CoV-2 virulence protein factor Nsp1.

 Feb/22/2021
Export (.csv)